Potent Cannabis Products Linked to Psychosis, Mental Health Risks

Potent Cannabis Products Linked to Psychosis, Mental Health Risks

(MedPage Today) -- Cannabis products containing high concentrations of delta-9-tetrahydrocannabinol (THC) -- the main psychoactive compound in marijuana -- were linked to psychosis, schizophrenia, and addiction, a systematic review found....

High concentration THC associated with schizophrenia, psychosis and other unfavorable mental health outcomes

A systematic review analyzed the associations of high-concentration delta-9-tetrahydrocannabinol (THC) cannabis products with mental health outcomes. The review found that high-concentration THC products are associated with unfavorable mental health outcomes, particularly for psychosis or schizophrenia and cannabis use disorder (CUD).

High-THC Cannabis Linked to Psychosis and Addiction

A systematic review of nearly 100 studies found that high-THC cannabis products are linked to negative mental health outcomes, particularly psychosis, schizophrenia, and cannabis use disorder. While some therapeutic research hinted at benefits for anxiety and depression, results were inconsistent and often showed potential harm.

High THC Concentrations Linked to Schizophrenia, Psychosis, and Adverse

In an increasingly cannabis-friendly world, a comprehensive new systematic review sheds critical light on the mental health risks posed by high-concentration delta-9-tetrahydrocannabinol (THC) products. Published in the upcoming issue of Annals of Internal Medicine, this expansive review synthesizes data from nearly half a century of research to reveal compelling associations between intense THC exposure and serious mental health disorders, incl…

High concentration THC linked to schizophrenia, psychosis, and other u